| Followers | 2 |
| Posts | 114 |
| Boards Moderated | 0 |
| Alias Born | 06/05/2024 |
Thursday, August 29, 2024 12:10:08 PM
I have traded so many shares in the last few weeks and months that have issued new shares or announced new shares and closed in these huge volumes within the day.
You can see from the trading that the share wants to rise and will rise in line with the positive approval and the expected increase in profits and income.
It is simply our basic evil with these short addresses that are now headlessly beating up on every share that is even slightly up, regardless of whether there is good or bad news.
But this headless beating on shares very often brings the next 100-200% plus in trading the next day, because they then close the open positions as quickly as possible at all costs and then try the game all over again later out of sheer anger.
It is therefore no wonder why so many of them go bust. Well, it's not their money, but only that of their investors in these funds.
You can see from the trading that the share wants to rise and will rise in line with the positive approval and the expected increase in profits and income.
It is simply our basic evil with these short addresses that are now headlessly beating up on every share that is even slightly up, regardless of whether there is good or bad news.
But this headless beating on shares very often brings the next 100-200% plus in trading the next day, because they then close the open positions as quickly as possible at all costs and then try the game all over again later out of sheer anger.
It is therefore no wonder why so many of them go bust. Well, it's not their money, but only that of their investors in these funds.
Recent BCDA News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 12:00:08 PM
- BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures • GlobeNewswire Inc. • 04/28/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:04:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:00:09 PM
- BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:30:15 PM
- BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure • GlobeNewswire Inc. • 04/02/2026 02:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:05:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:31:26 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2026 08:30:33 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/24/2026 08:05:25 PM
- BioCardia Reports 2025 Business Highlights and Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 • GlobeNewswire Inc. • 03/19/2026 11:47:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 10:02:10 AM
- BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA • GlobeNewswire Inc. • 03/17/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 01:01:30 PM
- BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 02:15:23 PM
- BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart • GlobeNewswire Inc. • 02/10/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 10:47:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 01:00:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/18/2025 10:13:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:00:11 PM
- BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA • GlobeNewswire Inc. • 12/16/2025 01:00:00 PM
